Section Arrow
Quote
THRD.NASDAQ
- Third Harmonic Bio
Quotes are at least 15-min delayed:2025/07/22 03:42 EDT
Regular Hours
Last
 5.43
-0.02 (-0.37%)
Day High 
5.46 
Prev. Close
5.45 
1-M High
5.525 
Volume 
717.42K 
Bid
--
Ask
--
Day Low
5.4 
Open
5.45 
1-M Low
5.4 
Market Cap 
245.95M 
Currency USD 
P/E 15.33 
%Yield -- 
10-SMA 5.45 
20-SMA 5.44 
50-SMA 5.32 
52-W High 16.02 
52-W Low 3.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.24/-2.50
Enterprise Value
248.30M
Balance Sheet
Book Value Per Share
6.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNFATNF Pharmaceuticals Inc.0.1294+0.0419+47.89%-- 
NCNANuCana plc0.051+0.0033+6.92%-- 
PMNProMIS Neurosciences1.12+0.6799+154.49%5PE
SABSSAB Biotherapeutics2.7+0.13+5.06%-- 
RXRXRecursion Pharmaceuticals6.4+0.56+9.59%-- 
Quotes are at least 15-min delayed：2025/07/22 03:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.